Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEET

v3.20.2
CONSOLIDATED BALANCE SHEET - USD ($)
May 31, 2020
Aug. 31, 2019
Current    
Cash and cash equivalents $ 2,034,011 $ 1,285,147
Marketable securities (Note 20) 18,277 64,214
Accounts receivable (Note 7) 253,960 273,145
Inventory (Note 8) 132,923 127,396
Prepaid expenses and deposit (Note 18) 88,940 68,927
Total Current Assets 2,528,111 1,818,829
Capital assets, net    
Intellectual Property (Note 9) 280,870 265,127
Property & equipment (Note 10) 511,281 591,263
Total Noncurrent Assets 792,151 856,390
TOTAL ASSETS 3,320,262 2,675,219
Current    
Accounts payable and accrued liabilities (Note 11) 55,127 136,411
Deferred revenue 6,250  
Due to a related party (Note 15) 29,595 48,096
Total Current Liabilities 90,972 184,507
Long Term    
Loan payable (Note 19) 28,756  
Total non Current Liabilities 28,756  
TOTAL LIABILITIES 119,728 184,507
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 89,587,090 common shares at May 31, 2020 and 78,787,134 common shares at August 31, 2019 89,587 78,787
Additional paid-in capital 30,184,383 26,172,453
Deficit (27,087,240) (23,868,202)
Equity attributable to shareholders of the Company 3,186,730 2,383,038
Non-Controlling Interest 13,804 107,674
Total Stockholders' Equity 3,200,534 2,490,712
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,320,262 $ 2,675,219